Stammdaten
Corcept Therapeutics Incorporated entdeckt, entwickelt und vermarktet Arzneimittel zur Behandlung schwerer Stoffwechsel-, onkologischer und neuropsychiatrischer Störungen in den Vereinigten Staaten. Das Unternehmen bietet Korlym (Mifepriston) Tabletten als täglich einzunahmendes orales Medikament zur Behandlung von Hyperglykämie sekundär zu Hyperkortisolismus bei erwachsenen Patienten mit endogenem Cushing-Syndrom, die an Diabetes mellitus Typ 2 oder Glukoseintoleranz leiden und bei denen eine Operation fehlgeschlagen ist oder die keine Kandidaten für eine Operation sind. Das Unternehmen entwickelt Relacorilant zur Behandlung von Patienten mit Cushing-Syndrom sowie nab-Paclitaxel in Kombination mit Relacorilant, das die Phase-II-Kliniktrial für die Behandlung von Patienten mit fortgeschrittenen Ovarialtumoren abgeschlossen hat, sowie für die Behandlung von Cortisolüberschuss. Das Unternehmen entwickelt zudem selektive Cortisol-Modulatoren zur Behandlung von Patienten mit metastasierendem kastrationsresistentem Prostatakrebs, selektive Cortisol-Modulatoren zur Behandlung von Antipsychotika-induzierter Gewichtszunahme und anderen Störungen sowie FKBP5-Genexpressionsassays. Corcept Therapeutics Incorporated wurde 1998 gegründet und hat seinen Sitz in Menlo Park, Kalifornien. KI
Unternehmen & Branche
| Name | CORCEPT THERAPEUTICS INC |
|---|---|
| Ticker | CORT |
| CIK | 0001088856 |
| Börse | Nasdaq |
| Sektor | Gesundheit |
| Industrie | Pharmazeutische Erzeugnisse |
| SIC | 2834 · Pharmaceutical Preparations |
Wertpapier & Kennzahlen
| CUSIP | 218352102 |
|---|---|
| ISIN | US2183521028 |
| Typ | Common Stock |
| Marktkapitalisierung | 10,10 Mrd. USD |
| KGV (P/E) | 116,29 |
| Beta | 0,47 |
| Dividendenrendite | 0,00 % |
Sitz & Kontakt
| Sitz (Inkorporation) | DE |
|---|---|
| Geschäftsadresse | 101 REDWOOD SHORES PARKWAY, 94065 REDWOOD CITY, CA |
| Telefon | 650.688.8803 |
| EIN (IRS) | 77-0487658 |
Listing & Historie
| Listing-Börsen | Nasdaq |
|---|---|
| Fiskaljahr-Ende | 31.12. |
| SEC-Filer-Status | Large accelerated filer |
Bewertung
| KBV (P/B) | 15,60 vs. 5,58 (2021) ▲ |
|---|---|
| KUV (P/S) | 13,27 vs. 5,73 (2021) ▲ |
| EV/EBITDA | 217,4 vs. 16,1 (2021) ▲ |
| FCF-Rendite | 1,4 % vs. 8,0 % (2021) ▼ |
| Buyback-Rendite | 1,7 % |
Qualität & Bilanz
| Bruttomarge | 98,3 % vs. 98,6 % (2021) ≈ |
|---|---|
| Operative Marge | 5,9 % vs. 34,0 % (2021) ▼ |
| Nettomarge | 13,1 % vs. 30,7 % (2021) ▼ |
| ROIC | 15,2 % vs. 29,9 % (2021) ▼ |
| Nettoverschuldung/EBITDA | -2,5 vs. -0,6 (2021) ▼ |
| Forderungslaufzeit (DSO) | 29 T vs. 28 T (2021) ▲ |
Basis: SEC-XBRL-Jahresabschluss bis 31.12.2025, Multiples mit aktueller Marktkapitalisierung (trailing), Vergleich: GJ bis 2021. Kennzahlen erklärt →
Kennzahlen-Historie (5 Jahre) – Tabelle & Verlauf
| Kennzahl | 2021 | 2022 | 2023 | 2024 | 2025 | TTM* | Verlauf |
|---|---|---|---|---|---|---|---|
| Bewertung | |||||||
| KBV (P/B) | 5,58 | 4,36 | 6,63 | 7,79 | 5,69 | 15,84 | |
| KUV (P/S) | 5,73 | 5,45 | 6,96 | 7,85 | 4,84 | 13,14 | |
| EV/EBITDA | 16,1 | – | 29,8 | 37,6 | 77,8 | – | |
| FCF-Rendite | 8,0 % | 5,5 % | 3,8 % | 3,7 % | 3,8 % | 1,2 % | |
| Buyback-Rendite | – | 0,0 % | 0,0 % | 0,3 % | 4,7 % | 1,4 % | |
| Qualität & Bilanz | |||||||
| Bruttomarge | 98,6 % | 98,7 % | 98,7 % | 98,4 % | 98,3 % | 98,3 % | |
| Operative Marge | 34,0 % | 28,0 % | 22,2 % | 20,3 % | 5,9 % | -1,1 % | |
| Nettomarge | 30,7 % | 25,2 % | 22,0 % | 20,9 % | 13,1 % | 6,2 % | |
| ROIC | 29,9 % | 20,2 % | 20,9 % | 20,6 % | 15,2 % | 7,3 % | |
| Nettoverschuldung/EBITDA | -0,6 | – | -1,2 | -0,9 | -2,5 | – | |
Basis: SEC-XBRL-Jahresabschlüsse, Multiples je Geschäftsjahr mit Marktkapitalisierung zum Bilanzstichtag (point-in-time).
TTM* = letzte zwölf Monate (vorläufig, ungeprüft): jüngstes Geschäftsjahr + laufendes YTD − Vorjahres-YTD aus den Quartalsberichten (10-Q); Bewertungs-Multiples gegen die aktuelle Marktkapitalisierung. Kein testierter Jahresabschluss.
Externe Quelle:
SEC EDGAR »
Externe Links: Yahoo Finance » · OnVista »
Glück Conviction Score™ ⓘ
Score-Verlauf (90 Tage)
Kursverlauf (24 Monate)
Indexierte Darstellung (Start = 100) — die Kursform bleibt sichtbar, absolute Kurse sind angemeldeten Mitgliedern vorbehalten.
Technische Indikatoren
Technical-Score basiert auf 12 Indikatoren (Trend, Momentum, Volatilität, Position) mit fixen Gewichten — wird aktuell nur informativ angezeigt und fließt nicht in den Glück Conviction Score ein. Integration nach Backtest-Kalibrierung (P5).
| Indikator | Signal | Gewicht | Wert | Detail | Beitrag |
|---|---|---|---|---|---|
| Kurs vs SMA50 | Bullisch | 10 % | 79.90 | +14.0 % vs SMA50 | |
| Kurs vs SMA200 | Bullisch | 15 % | 61.32 | +48.6 % vs SMA200 | |
| SMA-Cross | Bullisch | 10 % | GOLDEN | vor 23 Tagen @ 79.85 | |
| EMA20 vs EMA50 | Bullisch | 5 % | 90.04 | EMA50: 80.28 | |
| MACD-Histogramm | Bärisch | 10 % | -0.600 | Bearisch | |
| RSI(14) | Neutral | 10 % | 55.3 | Neutral (30–70) | |
| Stoch %K(14) | Neutral | 5 % | 48.9 | Neutral | |
| ADX(14)+DI | Bullisch | 10 % | 38.8 | +DI: 21.9 / −DI: 18.5 | |
| Z-Score(60) | Neutral | 5 % | 1.04 | In Range | |
| 52W-Position | Bullisch | 5 % | 91.4 % | Hoch 96.66 / Tief 32.15 | |
| Bollinger(20,2σ) | Neutral | 5 % | 49.0 % | Upper 96.79 / Mid 91.23 / Lower 85.68 | |
| LinReg-Slope(60) | Bullisch | 10 % | +0.8555 | R²=0.94 / annualisiert +286.8 % |
Insider-Transaktionen (12 Monate) ⓘ
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-07-15 | Mokari Atabak | Officer, Chief Financial Officer | Open Market Sale | -101 | 89,43 | -9.032,25 | -1,0% | |
| 2026-07-15 | WILSON JAMES N | Director | Open Market Sale | -3.969 | 87,74 | -348.222,60 | -37,4% | |
| 2026-07-15 | WILSON JAMES N | Director | Open Market Sale | -2.974 | 88,81 | -264.122,43 | -28,3% | |
| 2026-07-15 | WILSON JAMES N | Director | Open Market Sale | -1.978 | 89,49 | -177.007,46 | -19,0% | |
| 2026-07-15 | WILSON JAMES N | Director | Open Market Sale | -1.079 | 86,78 | -93.633,14 | -10,0% | |
| 2026-07-15 | Mokari Atabak | Officer, Chief Financial Officer | Open Market Sale | -28.460 | 87,89 | -2.501.244,10 | -268,4% | |
| 2026-07-15 | Mokari Atabak | Officer, Chief Financial Officer | Open Market Sale | -7.919 | 86,78 | -687.179,14 | -73,7% | |
| 2026-07-15 | Mokari Atabak | Officer, Chief Financial Officer | Open Market Sale | -3.520 | 88,30 | -310.821,63 | -33,4% | |
| 2026-07-07 | Guyer William | Officer, Chief Development Officer | Open Market Sale | -19.048 | 93,11 | -1.773.481,18 | -190,3% | |
| 2026-07-07 | Guyer William | Officer, Chief Development Officer | Open Market Sale | -952 | 93,54 | -89.048,46 | -9,6% | |
| 2026-07-01 | Maduck Sean | Officer, See Remarks | Open Market Sale | -2.801 | 88,51 | -247.924,07 | -26,6% | |
| 2026-07-01 | Maduck Sean | Officer, See Remarks | Open Market Sale | -11.175 | 89,31 | -998.032,55 | -107,1% | |
| 2026-07-01 | Maduck Sean | Officer, See Remarks | Open Market Sale | -11.024 | 87,33 | -962.779,94 | -103,3% | |
| 2026-06-17 | MAHONEY DAVID L | Director | Open Market Sale | -20.000 | 84,53 | -1.690.506,00 | -181,4% | |
| 2026-06-16 | WILSON JAMES N | Director | Open Market Sale | -4.177 | 82,69 | -345.416,18 | -37,1% | |
| 2026-06-16 | WILSON JAMES N | Director | Open Market Sale | -5.823 | 83,57 | -486.632,77 | -52,2% | |
| 2026-06-15 | Mokari Atabak | Officer, Chief Financial Officer | Open Market Sale | -2 | 82,45 | -164,90 | 0,0% | |
| 2026-06-15 | Mokari Atabak | Officer, Chief Financial Officer | Open Market Sale | -19.483 | 81,81 | -1.593.888,64 | -171,0% | |
| 2026-06-15 | Mokari Atabak | Officer, Chief Financial Officer | Open Market Sale | -11.081 | 80,94 | -896.922,73 | -96,2% | |
| 2026-06-15 | Mokari Atabak | Officer, Chief Financial Officer | Open Market Sale | -9.434 | 80,02 | -754.923,77 | -81,0% | |
| 2026-06-02 | Guyer William | Officer, Chief Development Officer | Open Market Sale | -20.000 | 70,60 | -1.412.000,00 | -151,5% | |
| 2026-06-01 | Maduck Sean | Officer, See Remarks | Open Market Sale | -21.069 | 70,11 | -1.477.080,17 | -158,5% | |
| 2026-06-01 | Maduck Sean | Officer, See Remarks | Open Market Sale | -3.931 | 70,75 | -278.103,31 | -29,8% | |
| 2026-06-01 | Mokari Atabak | Officer, Chief Financial Officer | Open Market Sale | -40.000 | 70,00 | -2.800.004,00 | -300,5% | |
| 2026-06-01 | BELANOFF JOSEPH K | Director, Officer, Chief Executive Officer | Open Market Sale | -12.837 | 69,74 | -895.252,38 | -96,1% | |
| 2026-05-27 | Maduck Sean | Officer, See Remarks | Open Market Sale | -20.425 | 66,16 | -1.351.315,96 | -145,0% | |
| 2026-05-27 | Lyon Joseph Douglas | Officer, See Remarks | Open Market Sale | -5.000 | 65,00 | -325.000,00 | -34,9% | |
| 2026-05-27 | Maduck Sean | Officer, See Remarks | Open Market Sale | -54.575 | 65,37 | -3.567.627,78 | -382,8% | |
| 2026-05-05 | Guyer William | Officer, Chief Development Officer | Open Market Sale | -20.000 | 51,83 | -1.036.600,00 | -111,2% | |
| 2026-05-01 | BELANOFF JOSEPH K | Director, Officer, Chief Executive Officer | Open Market Sale | -40.000 | 50,10 | -2.003.860,00 | -215,0% | |
| 2026-04-07 | Guyer William | Officer, Chief Development Officer | Open Market Sale | -20.000 | 40,97 | -819.400,00 | -87,9% | |
| 2026-03-25 | BELANOFF JOSEPH K | Director, Officer, Chief Executive Officer | Open Market Sale | -26.198 | 50,07 | -1.311.825,55 | -140,8% | |
| 2026-03-20 | Guyer William | Officer, Chief Development Officer | Open Market Sale | -11.767 | 36,01 | -423.729,67 | -45,5% | |
| 2026-03-17 | BAKER G LEONARD JR | Director | Open Market Purchase | 75.782 | 33,00 | 2.500.972,72 | +268,4% | |
| 2026-03-17 | BAKER G LEONARD JR | Director | Open Market Purchase | 24.218 | 33,56 | 812.836,00 | +87,2% | |
| 2026-03-04 | Guyer William | Officer, Chief Development Officer | Open Market Sale | -8.233 | 35,99 | -296.346,01 | -31,8% | |
| 2026-02-03 | Guyer William | Officer, Chief Development Officer | Open Market Sale | -20.000 | 40,87 | -817.334,00 | -87,7% | |
| 2026-01-06 | Guyer William | Officer, Chief Development Officer | Open Market Sale | -20.000 | 35,18 | -703.656,00 | -75,5% | |
| 2025-12-02 | Guyer William | Officer, Chief Development Officer | Open Market Sale | -640 | 80,88 | -51.760,00 | -5,6% | |
| 2025-12-02 | Guyer William | Officer, Chief Development Officer | Open Market Sale | -19.360 | 80,05 | -1.549.766,06 | -166,3% | |
| 2025-12-01 | BELANOFF JOSEPH K | Director, Officer, Chief Executive Officer | Open Market Sale | -40.000 | 79,77 | -3.190.796,00 | -342,4% | |
| 2025-11-25 | Guyer William | Officer, Chief Development Officer | Open Market Sale | -4.500 | 80,90 | -364.070,25 | -39,1% | |
| 2025-11-25 | Guyer William | Officer, Chief Development Officer | Open Market Sale | -4.500 | 80,90 | -364.070,25 | -39,1% | |
| 2025-11-05 | BELANOFF JOSEPH K | Director, Officer, Chief Executive Officer | Open Market Sale | -3.590 | 75,98 | -272.759,94 | -29,3% | |
| 2025-11-05 | Guyer William | Officer, Chief Development Officer | Open Market Sale | -13.164 | 75,64 | -995.678,89 | -106,8% | |
| 2025-11-05 | Guyer William | Officer, Chief Development Officer | Open Market Sale | -6.536 | 74,75 | -488.558,81 | -52,4% | |
| 2025-11-05 | Guyer William | Officer, Chief Development Officer | Open Market Sale | -300 | 76,28 | -22.884,00 | -2,5% | |
| 2025-11-05 | BELANOFF JOSEPH K | Director, Officer, Chief Executive Officer | Open Market Sale | -14.355 | 74,20 | -1.065.083,58 | -114,3% | |
| 2025-11-05 | BELANOFF JOSEPH K | Director, Officer, Chief Executive Officer | Open Market Sale | -10.837 | 75,14 | -814.261,84 | -87,4% | |
| 2025-11-03 | BELANOFF JOSEPH K | Director, Officer, Chief Executive Officer | Open Market Sale | -11.218 | 74,08 | -831.013,73 | -89,2% | |
| 2025-10-10 | Swisher Daniel N JR | Director | Open Market Sale | -2.200 | 87,54 | -192.588,00 | -20,7% | |
| 2025-10-07 | Guyer William | Officer, Chief Development Officer | Open Market Sale | -20.000 | 89,94 | -1.798.782,00 | -193,0% | |
| 2025-10-01 | BELANOFF JOSEPH K | Director, Officer, Chief Executive Officer | Open Market Sale | -3.194 | 85,67 | -273.617,84 | -29,4% | |
| 2025-10-01 | BELANOFF JOSEPH K | Director, Officer, Chief Executive Officer | Open Market Sale | -31.190 | 85,16 | -2.656.265,16 | -285,0% | |
| 2025-10-01 | BELANOFF JOSEPH K | Director, Officer, Chief Executive Officer | Open Market Sale | -5.616 | 84,29 | -473.369,83 | -50,8% | |
| 2025-09-10 | Swisher Daniel N JR | Director | Open Market Sale | -2.200 | 72,45 | -159.390,00 | -17,1% | |
| 2025-09-02 | BELANOFF JOSEPH K | Director, Officer, Chief Executive Officer | Open Market Sale | -700 | 71,01 | -49.707,49 | -5,3% | |
| 2025-09-02 | Guyer William | Officer, Chief Development Officer | Open Market Sale | -15.594 | 70,39 | -1.097.692,85 | -117,8% | |
| 2025-09-02 | Guyer William | Officer, Chief Development Officer | Open Market Sale | -4.406 | 70,85 | -312.155,41 | -33,5% | |
| 2025-09-02 | BELANOFF JOSEPH K | Director, Officer, Chief Executive Officer | Open Market Sale | -39.300 | 70,52 | -2.771.325,96 | -297,4% | |
| 2025-08-22 | Robb Gary Charles | Officer, Chief Business Officer | Open Market Sale | -2.326 | 71,27 | -165.774,02 | -17,8% | |
| 2025-08-11 | Swisher Daniel N JR | Director | Open Market Sale | -2.200 | 72,30 | -159.060,00 | -17,1% | |
| 2025-08-08 | Guyer William | Officer, Chief Development Officer | Open Market Sale | -35.007 | 71,77 | -2.512.452,39 | -269,6% | |
| 2025-08-05 | Guyer William | Officer, Chief Development Officer | Open Market Sale | -14 | 71,77 | -1.004,78 | -0,1% | |
| 2025-08-01 | BELANOFF JOSEPH K | Director, Officer, Chief Executive Officer | Open Market Sale | -16.745 | 67,81 | -1.135.416,49 | -121,8% | |
| 2025-08-01 | BELANOFF JOSEPH K | Director, Officer, Chief Executive Officer | Open Market Sale | -17.809 | 68,87 | -1.226.486,24 | -131,6% | |
| 2025-08-01 | BELANOFF JOSEPH K | Director, Officer, Chief Executive Officer | Open Market Sale | -5.446 | 69,65 | -379.304,64 | -40,7% |
Fondsaktivität (Vorquartalsvergleich) ⓘ
⚠ Vorläufige Daten: Erst 2951 von typischerweise 8401 Fonds (35 %) haben für das aktuelle 13F-Quartal eingereicht — Werte können sich in den kommenden Wochen noch deutlich ändern.
| Fonds | Aktuell (Stk) | Vorquartal (Stk) | Veränderung (Stk) | Wert (USD) | Status | Δ | Trend |
|---|---|---|---|---|---|---|---|
| BlackRock, Inc. | 12.151.276 | 0 | 12.151.276 | 489.817.956 | Neu | +100,0% | |
| RENAISSANCE TECHNOLOGIES LLC | 5.682.783 | 0 | 5.682.783 | 229.072.983 | Neu | +100,0% | |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.077.196 | 0 | 4.077.196 | 164.351.771 | Neu | +100,0% | |
| Parallel Advisors, LLC | 3.977.404 | 0 | 3.977.404 | 160.329.155 | Neu | +100,0% | |
| STATE STREET CORP | 3.200.946 | 0 | 3.200.946 | 129.030.133 | Neu | +100,0% | |
| FMR LLC | 3.190.192 | 0 | 3.190.192 | 128.596.647 | Neu | +100,0% | |
| GEODE CAPITAL MANAGEMENT, LLC | 2.713.519 | 0 | 2.713.519 | 109.399.340 | Neu | +100,0% | |
| FIRST TRUST ADVISORS LP | 2.173.376 | 0 | 2.173.376 | 87.608.786 | Neu | +100,0% | |
| DIMENSIONAL FUND ADVISORS LP | 1.553.135 | 0 | 1.553.135 | 62.596.749 | Neu | +100,0% | |
| TANG CAPITAL MANAGEMENT LLC | 1.500.000 | 0 | 1.500.000 | 60.465.000 | Neu | +100,0% | |
| Caption Management, LLC | 1.415.100 | 0 | 1.415.100 | 57.042.681 | Neu | +100,0% | |
| UBS Group AG | 1.363.668 | 0 | 1.363.668 | 54.969.457 | Neu | +100,0% | |
| JANE STREET GROUP, LLC | 1.268.545 | 0 | 1.268.545 | 51.135.049 | Neu | +100,0% | |
| D. E. Shaw & Co., Inc. | 1.181.348 | 0 | 1.181.348 | 47.620.138 | Neu | +100,0% | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1.119.959 | 0 | 1.119.959 | 45.145.547 | Neu | +100,0% | |
| MORGAN STANLEY | 1.018.845 | 0 | 1.018.845 | 41.069.730 | Neu | +100,0% | |
| MPM BioImpact LLC | 985.700 | 0 | 985.700 | 39.733.567 | Neu | +100,0% | |
| Boston Trust Walden Corp | 440.264 | 462.606 | -22.342 | 38.280.954 | Reduziert | -4,8% | |
| TWO SIGMA INVESTMENTS, LP | 945.884 | 0 | 945.884 | 38.128.584 | Neu | +100,0% | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 905.831 | 0 | 905.831 | 36.514.048 | Neu | +100,0% | |
| Cerity Partners LLC | 731.689 | 0 | 731.689 | 29.494.383 | Neu | +100,0% | |
| GOLDMAN SACHS GROUP INC | 725.822 | 0 | 725.822 | 29.257.885 | Neu | +100,0% | |
| Sio Capital Management, LLC | 674.759 | 0 | 674.759 | 27.199.535 | Neu | +100,0% | |
| NORTHERN TRUST CORP | 643.158 | 0 | 643.158 | 25.925.699 | Neu | +100,0% | |
| MILLENNIUM MANAGEMENT LLC | 558.747 | 0 | 558.747 | 22.523.092 | Neu | +100,0% | |
| CITADEL ADVISORS LLC | 544.620 | 0 | 544.620 | 21.953.632 | Neu | +100,0% | |
| PRINCIPAL FINANCIAL GROUP INC | 455.248 | 0 | 455.248 | 18.351.046 | Neu | +100,0% | |
| CITIGROUP INC | 421.067 | 0 | 421.067 | 16.973.211 | Neu | +100,0% | |
| AQR CAPITAL MANAGEMENT LLC | 406.205 | 0 | 406.205 | 15.874.483 | Neu | +100,0% | |
| GROUP ONE TRADING LLC | 368.486 | 0 | 368.486 | 14.853.671 | Neu | +100,0% | |
| PUBLIC SECTOR PENSION INVESTMENT BOARD | 334.875 | 0 | 334.875 | 13.498.811 | Neu | +100,0% | |
| CANADA PENSION PLAN INVESTMENT BOARD | 324.901 | 0 | 324.901 | 13.096.759 | Neu | +100,0% | |
| FAS Wealth Partners, Inc. | 322.370 | 0 | 322.370 | 12.994.735 | Neu | +100,0% | |
| FRANKLIN RESOURCES INC | 305.211 | 0 | 305.211 | 12.303.055 | Neu | +100,0% | |
| KENNEDY CAPITAL MANAGEMENT LLC | 304.615 | 0 | 304.615 | 12.279.031 | Neu | +100,0% | |
| Soleus Capital Management, L.P. | 285.531 | 0 | 285.531 | 11.509.755 | Neu | +100,0% | |
| Voleon Capital Management LP | 262.223 | 0 | 262.223 | 10.570.209 | Neu | +100,0% | |
| Boxer Capital Management, LLC | 250.000 | 0 | 250.000 | 10.077.500 | Neu | +100,0% | |
| Allspring Global Investments Holdings, LLC | 214.572 | 0 | 214.572 | 9.007.732 | Neu | +100,0% | |
| Legal & General Group Plc | 219.680 | 0 | 219.680 | 8.855.286 | Neu | +100,0% | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 217.468 | 0 | 217.468 | 8.766.136 | Neu | +100,0% | |
| AMERIPRISE FINANCIAL INC | 212.074 | 0 | 212.074 | 8.548.702 | Neu | +100,0% | |
| EMERALD ADVISERS, LLC | 205.558 | 0 | 205.558 | 8.286.043 | Neu | +100,0% | |
| Trexquant Investment LP | 194.041 | 0 | 194.041 | 7.821.793 | Neu | +100,0% | |
| SIMPLEX TRADING, LLC | 192.815 | 0 | 192.815 | 7.772.372 | Neu | +100,0% | |
| Nuveen, LLC | 191.904 | 0 | 191.904 | 7.735.651 | Neu | +100,0% | |
| RHUMBLINE ADVISERS | 190.698 | 0 | 190.698 | 7.686.995 | Neu | +100,0% | |
| Swiss National Bank | 186.965 | 0 | 186.965 | 7.536.559 | Neu | +100,0% | |
| BROWN CAPITAL MANAGEMENT LLC | 84.041 | 93.693 | -9.652 | 7.307.365 | Reduziert | -10,3% | |
| EMERALD MUTUAL FUND ADVISERS TRUST | 179.607 | 0 | 179.607 | 7.239.958 | Neu | +100,0% |
Top-Fondshalter (Stand: 30.06.2026) ⓘ
⚠ Vorläufige Daten: Erst 2951 von typischerweise 8401 Fonds (35 %) haben für dieses Quartal eingereicht. Vollständigkeit erwartet bis 14.08.2026. Auswertungen (NEW/INC/DEC) sind noch zu konservativ — viele Spätfiler erscheinen aktuell als „Exits".
| Fonds | Anteile | Vorquartal (Stk) | Δ | Wert (USD) | Anteil (%) | Stimmkontrolle | Verlauf |
|---|---|---|---|---|---|---|---|
| Boston Trust Walden Corp | 440.264 | 462.606 | -4,8% | 38.280.954 | 37,33 | 92 % | 17 Q |
| BROWN CAPITAL MANAGEMENT LLC | 84.041 | 93.693 | -10,3% | 7.307.365 | 7,13 | 100 % | 4 Q |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | 76.278 | 0 | +100,0% | 6.648.944 | 6,48 | 48 % | 7 Q |
| Hennion & Walsh Asset Management, Inc. | 45.429 | 45.979 | -1,2% | 3.950.052 | 3,85 | 100 % | 15 Q |
| Police & Firemen's Retirement System of New Jersey | 43.354 | 40.592 | +6,8% | 3.769.630 | 3,68 | 100 % | 7 Q |
| Louisiana State Employees Retirement System | 41.900 | 41.500 | +1,0% | 3.643.205 | 3,55 | 100 % | 17 Q |
| Linden Thomas Advisory Services, LLC | 34.641 | 61.250 | -43,4% | 3.012.035 | 2,94 | 0 % | 13 Q |
| OAK RIDGE INVESTMENTS LLC | 34.172 | 24.870 | +37,4% | 2.971.255 | 2,90 | 90 % | 9 Q |
| Simplify Asset Management Inc. | 26.434 | 37.763 | -30,0% | 2.298.436 | 2,24 | 100 % | 2 Q |
| YOUSIF CAPITAL MANAGEMENT, LLC | 23.189 | 22.873 | +1,4% | 2.016.284 | 1,97 | 16 % | 17 Q |
| COMMONWEALTH OF PENNSYLVANIA PUBLIC SCHOOL EMPLS RETRMT SYS | 22.657 | 23.151 | -2,1% | 1.970.026 | 1,92 | 100 % | 17 Q |
| OREGON PUBLIC EMPLOYEES RETIREMENT FUND | 21.676 | 21.376 | +1,4% | 1.884.728 | 1,84 | 100 % | 17 Q |
| Erste Asset Management GmbH | 18.300 | 18.300 | 0,0% | 1.608.387 | 1,57 | 100 % | 6 Q |
| CAMPBELL NEWMAN ASSET MANAGEMENT INC | 18.048 | 17.251 | +4,6% | 1.569.274 | 1,53 | 18 % | 17 Q |
| JAMES INVESTMENT RESEARCH, INC. | 17.122 | 17.122 | 0,0% | 1.488.758 | 1,45 | 100 % | 17 Q |
| TRUIST FINANCIAL CORP | 16.449 | 8.570 | +91,9% | 1.430.240 | 1,39 | 17 % | 13 Q |
| Concurrent Investment Advisors, LLC | 13.380 | 8.100 | +65,2% | 1.163.391 | 1,13 | 100 % | 6 Q |
| Evanson Financial, LLC | 12.478 | 0 | +100,0% | 1.084.962 | 1,06 | 0 % | 1 Q |
| Merit Financial Group, LLC | 11.908 | 0 | +100,0% | 1.035.401 | 1,01 | 0 % | 4 Q |
| Rathbones Group PLC | 11.790 | 0 | +100,0% | 1.025.140 | 1,00 | 100 % | 1 Q |
Halter-Trend (6 Quartale)
| Periode | Status | Halter | Anteile (Mio) | Wert (Mio $) |
|---|---|---|---|---|
| 30.06.2026 | vorl. | 91 | 1,5 | 105 |
| 31.03.2026 | ✓ | 347 | 87,7 | 3.174 |
| 31.12.2025 | ✓ | 384 | 78,5 | 2.430 |
| 30.09.2025 | ✓ | 426 | 79,2 | 5.807 |
| 30.06.2025 | ✓ | 417 | 78,9 | 5.181 |
| 31.03.2025 | ✓ | 414 | 86,3 | 8.501 |
Top 10 Neueinsteiger
| Fonds | Anteile | Wert (USD) |
|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | 4.077.196 | 164.351.771 |
| MPM BioImpact LLC | 985.700 | 39.733.567 |
| Sio Capital Management, LLC | 674.759 | 27.199.535 |
| Soleus Capital Management, L.P. | 285.531 | 11.509.755 |
| Voleon Capital Management LP | 262.223 | 10.570.209 |
| Caption Management, LLC | 260.000 | 10.480.600 |
| Boxer Capital Management, LLC | 250.000 | 10.077.500 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 230.731 | 9.300.767 |
| Susquehanna Portfolio Strategies, LLC | 177.147 | 7.140.796 |
| Propel Bio Management, LLC | 147.828 | 6.022.011 |
Top 10 Aufstocker
| Fonds | Anteile | Δ Anteile | Δ % | Wert (USD) |
|---|---|---|---|---|
| FIRST TRUST ADVISORS LP | 2.173.376 | 1.480.059 | +213.5 % | 87.608.786 |
| TANG CAPITAL MANAGEMENT LLC | 1.500.000 | 1.343.236 | +856.9 % | 60.465.000 |
| D. E. Shaw & Co., Inc. | 1.181.348 | 1.011.681 | +596.3 % | 47.620.138 |
| UBS Group AG | 1.363.668 | 948.817 | +228.7 % | 54.969.457 |
| TWO SIGMA INVESTMENTS, LP | 945.884 | 917.925 | +3283.1 % | 38.128.584 |
| FMR LLC | 3.190.192 | 775.552 | +32.1 % | 128.596.647 |
| MILLENNIUM MANAGEMENT LLC | 558.747 | 470.310 | +531.8 % | 22.523.092 |
| INGALLS & SNYDER LLC | 7.608.716 | 413.656 | +5.7 % | 306.707 |
| CITIGROUP INC | 421.067 | 386.938 | +1133.8 % | 16.973.211 |
| GOLDMAN SACHS GROUP INC | 725.822 | 294.846 | +68.4 % | 29.257.885 |
Top 10 Verkäufer
| Fonds | Anteile | Δ Anteile | Δ % | Wert (USD) |
|---|---|---|---|---|
| CITADEL ADVISORS LLC | 254.220 | -608.832 | -70.5 % | 10.247.608 |
| MORGAN STANLEY | 1.018.845 | -573.214 | -36.0 % | 41.069.730 |
| AQR CAPITAL MANAGEMENT LLC | 406.205 | -481.656 | -54.2 % | 15.874.483 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 86.590 | -297.656 | -77.5 % | 3.491 |
| Allspring Global Investments Holdings, LLC | 214.572 | -293.395 | -57.8 % | 9.007.732 |
| Caitong International Asset Management Co., Ltd | 362 | -251.270 | -99.9 % | 14.592 |
| Bridgewater Associates, LP | 38.422 | -240.578 | -86.2 % | 1.548.791 |
| Walleye Capital LLC | 1.000 | -179.401 | -99.4 % | 40.310 |
| BURNEY CO/ | 45.779 | -178.058 | -79.5 % | 1.845.351 |
| Neuberger Berman Group LLC | 6.895 | -175.069 | -96.2 % | 277.937 |
Zusätzlich aktuell von 152 Mutual Funds/ETFs gehalten (N-PORT). Alle Fondsgesellschaften & ihre 4-Quartals-Bewegungen →
Aktivisten & Großaktionäre (13D/13G) ⓘ
| Datum | Investor | Typ | Anteil | Aktien | Δ | Δ-Balken |
|---|---|---|---|---|---|---|
| 21.04.2026 | INGALLS & SNYDER LLC | Passiv (13G/A) | 6,80 % | 7.263.466 | -1,00 pp | |
| 26.03.2026 | The Vanguard Group | Passiv (13G/A) | Ausstieg | 0 | -9,25 pp | |
| 12.02.2026 | Renaissance Technologies Holdings Corporation (+1) | Passiv (13G/A) | 5,47 % | 5.758.528 | Neu | |
| 17.07.2025 | BlackRock, Inc. | Passiv (13G/A) | 10,90 % | 11.539.099 | -1,80 pp | |
| 23.04.2025 | BlackRock, Inc. | Passiv (13G/A) | 12,70 % | 13.349.143 | Neu | |
| 21.02.2025 | INGALLS & SNYDER LLC | Passiv (13G/A) | 7,80 % | 8.173.721 | Neu | |
| 14.02.2025 | Joseph K. Belanoff | Passiv (13G/A) | 6,30 % | 6.822.335 | +0,20 pp | |
| 27.03.2024 | INGALLS & SNYDER, LLC | Passiv (13G/A) | 8,00 % | 8.262.476 | +1,40 pp | |
| 14.02.2024 | G. Leonard Baker, Jr. | Passiv (13G/A) | 5,30 % | 5.512.696 | +0,20 pp | |
| 13.02.2024 | The Vanguard Group | Passiv (13G/A) | 9,25 % | 9.537.532 | -0,36 pp | |
| 13.02.2024 | RENAISSANCE TECHNOLOGIES HOLDINGS CORPORATION 13-3127734 (+1) | Passiv (13G/A) | 6,52 % | 6.725.871 | -0,25 pp | |
| 12.02.2024 | Joseph K. Belanoff | Passiv (13G/A) | 6,10 % | 6.581.918 | +0,60 pp | |
| 22.01.2024 | . BlackRock, Inc. | Passiv (13G/A) | 15,90 % | 16.407.696 | +0,70 pp | |
| 17.02.2023 | INGALLS & SNYDER, LLC | Passiv (13G/A) | 6,60 % | 7.090.370 | +0,90 pp | |
| 15.02.2023 | Joseph K. Belanoff | Passiv (13G/A) | 5,50 % | 6.081.918 | -0,30 pp | |
| 14.02.2023 | G. Leonard Baker, Jr. | Passiv (13G/A) | 5,10 % | 5.485.196 | -0,10 pp | |
| 13.02.2023 | RENAISSANCE TECHNOLOGIES HOLDINGS CORPORATION 13-3127734 (+1) | Passiv (13G/A) | 6,77 % | 7.288.871 | -0,18 pp | |
| 09.02.2023 | The Vanguard Group | Passiv (13G/A) | 9,61 % | 10.345.030 | -0,62 pp | |
| 26.01.2023 | . BlackRock, Inc. | Passiv (13G/A) | 15,20 % | 16.347.383 | 0,00 pp | |
| 20.01.2023 | . BlackRock, Inc. | Passiv (13G) | 15,20 % | 16.347.383 | +2,20 pp | |
| 09.03.2022 | The Vanguard Group | Passiv (13G/A) | 10,23 % | 10.844.789 | +0,88 pp | |
| 14.02.2022 | G. Leonard Baker, Jr. | Passiv (13G) | 5,20 % | 5.465.196 | Neu | |
| 11.02.2022 | Joseph K. Belanoff | Passiv (13G/A) | 5,80 % | 6.374.376 | +0,50 pp | |
| 11.02.2022 | RENAISSANCE TECHNOLOGIES HOLDINGS CORPORATION 13-3127734 (+1) | Passiv (13G/A) | 6,95 % | 8.023.616 | -1,09 pp | |
| 09.02.2022 | The Vanguard Group | Passiv (13G/A) | 9,35 % | 10.797.477 | -0,98 pp | |
| 04.02.2022 | INGALLS & SNYDER, LLC | Passiv (13G/A) | 5,70 % | 6.655.977 | -0,83 pp | |
| 28.01.2022 | . BlackRock, Inc. | Passiv (13G/A) | 13,00 % | 15.047.993 | -0,40 pp |
Finanzkennzahlen (SEC XBRL) ⓘ
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2026-03-31 | 10-Q | 164.903.000 $ | -31.761.000 $ | -0,30 $ | 814.881.000 $ | 637.987.000 $ |
| 2025-12-31 | 10-K | 761.407.000 $ | 99.652.000 $ | 0,82 $ | 836.651.000 $ | 647.805.000 $ |
| 2025-09-30 | 10-Q | 207.638.000 $ | 19.668.000 $ | 0,16 $ | 823.607.000 $ | 631.902.000 $ |
| 2025-06-30 | 10-Q | 194.430.000 $ | 35.149.000 $ | 0,29 $ | 801.722.000 $ | 635.793.000 $ |
| 2025-03-31 | 10-Q | 157.214.000 $ | 20.547.000 $ | 0,17 $ | 846.455.000 $ | 683.285.000 $ |
| 2024-12-31 | 10-K | 675.040.000 $ | 141.209.000 $ | 1,23 $ | 840.553.000 $ | 679.589.000 $ |
| 2024-09-30 | 10-Q | 182.546.000 $ | 47.213.000 $ | 0,41 $ | 784.257.000 $ | 638.835.000 $ |
| 2024-06-30 | 10-Q | 163.796.000 $ | 35.488.000 $ | 0,32 $ | 714.555.000 $ | 596.243.000 $ |
| 2024-03-31 | 10-Q | 146.808.000 $ | 27.762.000 $ | 0,25 $ | 655.935.000 $ | 547.864.000 $ |
| 2023-12-31 | 10-K | 482.375.000 $ | 106.140.000 $ | 0,94 $ | 621.517.000 $ | 506.705.000 $ |
| 2023-09-30 | 10-Q | 123.601.000 $ | 31.378.000 $ | 0,28 $ | 594.022.000 $ | 461.679.000 $ |
| 2023-06-30 | 10-Q | 117.715.000 $ | 27.528.000 $ | 0,25 $ | 524.625.000 $ | 421.614.000 $ |
| 2023-03-31 | 10-Q | 105.654.000 $ | 15.879.000 $ | 0,14 $ | 617.848.000 $ | 529.584.000 $ |
| 2022-12-31 | 10-K | 401.858.000 $ | 101.418.000 $ | 0,87 $ | 583.430.000 $ | 501.842.000 $ |
| 2022-09-30 | 10-Q | 101.728.000 $ | 34.608.000 $ | 0,30 $ | 533.255.000 $ | 473.364.000 $ |
| 2022-06-30 | 10-Q | 103.386.000 $ | 27.412.000 $ | 0,24 $ | 496.364.000 $ | 442.326.000 $ |
| 2022-03-31 | 10-Q | 93.688.000 $ | 22.797.000 $ | 0,20 $ | 468.123.000 $ | 407.811.000 $ |
| 2021-12-31 | 10-K | 365.978.000 $ | 112.512.000 $ | 0,89 $ | 423.756.000 $ | 375.806.000 $ |
| 2021-09-30 | 10-Q | 96.131.000 $ | 30.471.000 $ | 0,24 $ | 585.399.000 $ | 540.229.000 $ |
| 2021-06-30 | 10-Q | 91.588.000 $ | 26.523.000 $ | 0,21 $ | 568.480.000 $ | 522.675.000 $ |
Quartalsergebnisse (Earnings) ⓘ
| Quartal | Stichtag | Verkündet | Umsatz | EPS |
|---|---|---|---|---|
| Q1 2026 | 31.03.2026 | 30.04.2026 | 164,9 Mio. USD | -0,30 |
| Q3 2025 | 30.09.2025 | 04.11.2025 | 207,6 Mio. USD | 0,16 |
| Q2 2025 | 30.06.2025 | 31.07.2025 | 194,4 Mio. USD | 0,29 |
| Q1 2025 | 31.03.2025 | 05.05.2025 | 157,2 Mio. USD | 0,17 |
| Q3 2024 | 30.09.2024 | 30.10.2024 | 182,5 Mio. USD | 0,41 |
| Q2 2024 | 30.06.2024 | 29.07.2024 | 163,8 Mio. USD | 0,32 |
| Q1 2024 | 31.03.2024 | 01.05.2024 | 146,8 Mio. USD | 0,25 |
| Q3 2023 | 30.09.2023 | 01.11.2023 | 123,6 Mio. USD | 0,28 |
| Q2 2023 | 30.06.2023 | 02.08.2023 | 117,7 Mio. USD | 0,25 |
Dividenden
Dividende je Aktie (Jahr, SEC-XBRL)
| Jahr | DPS |
|---|---|
| 2013 | 0,0000 |
Beträge aus SEC-XBRL, Termine aus 8-K Item 8.01 (regelbasiert extrahiert, KI als Fallback), ohne Gewähr.
Einreichungs-Historie (10-K / 10-Q / 20-F / 6-K)
SEC-Einreichungs-Historie der letzten sechs Jahre (Datum = US-Kalendertag,
SEC/ET): Quartalsberichte (10-Q) und Jahresberichte (10-K); ausländische
Emittenten (ADR/Foreign Private Issuer) reichen stattdessen Jahresberichte
(20-F/40-F) und Zwischenmitteilungen (6-K) ein — dort liegt im SEC-Index
keine Berichtsperiode vor, Periode und Verzögerung bleiben leer. Die Spalte „Verzögerung" zeigt die
Tage zwischen Berichtsstichtag und tatsächlicher Einreichung.
Suffix /A kennzeichnet nachträgliche Berichtigungen.
| Eingereicht (US) | Form | Berichtsperiode | Verzögerung | |
|---|---|---|---|---|
| 30.04.2026 | 10-Q | 31.03.2026 | 30 Tage | SEC » |
| 24.02.2026 | 10-K | 31.12.2025 | 55 Tage | SEC » |
| 04.11.2025 | 10-Q | 30.09.2025 | 35 Tage | SEC » |
| 31.07.2025 | 10-Q | 30.06.2025 | 31 Tage | SEC » |
| 05.05.2025 | 10-Q | 31.03.2025 | 35 Tage | SEC » |
| 26.02.2025 | 10-K | 31.12.2024 | 57 Tage | SEC » |
| 30.10.2024 | 10-Q | 30.09.2024 | 30 Tage | SEC » |
| 29.07.2024 | 10-Q | 30.06.2024 | 29 Tage | SEC » |
| 01.05.2024 | 10-Q | 31.03.2024 | 31 Tage | SEC » |
| 15.02.2024 | 10-K | 31.12.2023 | 46 Tage | SEC » |
| 01.11.2023 | 10-Q | 30.09.2023 | 32 Tage | SEC » |
| 02.08.2023 | 10-Q | 30.06.2023 | 33 Tage | SEC » |
| 03.05.2023 | 10-Q | 31.03.2023 | 33 Tage | SEC » |
| 28.02.2023 | 10-K | 31.12.2022 | 59 Tage | SEC » |
| 03.11.2022 | 10-Q | 30.09.2022 | 34 Tage | SEC » |
| 04.08.2022 | 10-Q | 30.06.2022 | 35 Tage | SEC » |
| 05.05.2022 | 10-Q | 31.03.2022 | 35 Tage | SEC » |
| 15.02.2022 | 10-K | 31.12.2021 | 46 Tage | SEC » |
| 15.11.2021 | 10-K/A | 31.12.2020 | 319 Tage | SEC » |
| 03.11.2021 | 10-Q | 30.09.2021 | 34 Tage | SEC » |
| 29.07.2021 | 10-Q | 30.06.2021 | 29 Tage | SEC » |
| 06.05.2021 | 10-Q | 31.03.2021 | 36 Tage | SEC » |
| 23.02.2021 | 10-K | 31.12.2020 | 54 Tage | SEC » |
| 03.11.2020 | 10-Q | 30.09.2020 | 34 Tage | SEC » |
| 04.08.2020 | 10-Q | 30.06.2020 | 35 Tage | SEC » |
Proxy-/Governance-Filings
Proxy-Statements (SEC DEF-14A-Familie) der letzten sechs Jahre: reguläre HV-Einladungen zur Aktionärsversammlung, Aktivisten-Proxy-Fights (contested / Non-Management-Solicitation) und M&A-Abstimmungen.
| Datum (US) | Kategorie | HV-Termin (US) | Stichtag (US) | Form | |
|---|---|---|---|---|---|
| 17.04.2026 | HV-Einladung | 21.05.2026 Jahres-HV | 09.04.2026 | DEF 14A | SEC » |
| 25.04.2025 | HV-Einladung | 10.06.2025 Jahres-HV | 17.04.2025 | DEF 14A | SEC » |
| 18.04.2024 | HV-Einladung | — | — | DEFA14A | SEC » |
| 10.04.2024 | HV-Einladung | 17.05.2024 Jahres-HV | 05.04.2024 | DEF 14A | SEC » |
| 08.05.2023 | HV-Einladung | — | — | DEFA14A | SEC » |
| 14.04.2023 | HV-Einladung | 19.05.2023 Jahres-HV | 06.04.2023 | DEF 14A | SEC » |
| 04.04.2023 | Vorläufig | — | — | PRE 14A | SEC » |
| 25.04.2022 | HV-Einladung | 31.05.2022 Jahres-HV | 13.04.2022 | DEF 14A | SEC » |
| 22.04.2021 | HV-Einladung | 26.05.2021 Jahres-HV | 16.04.2021 | DEF 14A | SEC » |
Datum = US-Einreichungsdatum (SEC EDGAR, ET). HV-Termin = Datum der Aktionärsversammlung, Stichtag (Record Date) = Nachweisstichtag für die Stimmberechtigung (aus dem Dokument extrahiert).
Übernahmen & Fusionen (M&A)
M&A-relevante SEC-Filings der letzten sechs Jahre: Übernahmeangebote (Tender Offers), Fusionen (425/S-4), Aktienrückkauf-Angebote (Self-Tender) und Going-Private-Transaktionen. Geführt nach dem einreichenden Emittenten.
| Datum (US) | Kategorie | Form | Deal-Konditionen | SEC |
|---|---|---|---|---|
| 05.04.2023 | Aktienrückkauf | SC TO-I/A | – | SEC » |
| 03.04.2023 | Aktienrückkauf | SC TO-I/A | – | SEC » |
| 07.03.2023 | Aktienrückkauf | SC TO-I/A | – | SEC » |
| 06.03.2023 | Aktienrückkauf | SC TO-I | $19,25 Cash | SEC » |
| 20.12.2021 | Aktienrückkauf | SC TO-I/A | – | SEC » |
| 16.12.2021 | Aktienrückkauf | SC TO-I/A | – | SEC » |
| 15.12.2021 | Aktienrückkauf | SC TO-I/A | – | SEC » |
| 08.12.2021 | Aktienrückkauf | SC TO-I/A | – | SEC » |
| 08.11.2021 | Aktienrückkauf | SC TO-I | $20,75 Cash | SEC » |
Datum = US-Einreichungsdatum (SEC EDGAR, ET). Deal-Konditionen aus dem Dokument extrahiert (Tender: SC TO-T/-I/SC 14D9; Fusion: 425/S-4 — Gegenpartei + Umtauschverhältnis), ohne Gewähr — Original siehe SEC-Link.
Kritische 8-K Meldungen ⓘ
HOCH Abgang Schlüsselpersonen (28.05.2026)
| Datum | Meldung | Tags | Schwere | Filing | Auszug |
|---|---|---|---|---|---|
| 28.05.2026 | Item 5.02 — Abgang Schlüsselpersonen | – | HOCH | SEC | Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 23.05.2024 | Item 5.02 — Abgang Schlüsselpersonen | – | HOCH | SEC | Section 13(a) of the Exchange Act. ☐ Item 5.02 Departure of Directors or Certain Officers; Election of Directors… |
| 10.06.2021 | Item 5.02 — Abgang Schlüsselpersonen | – | HOCH | SEC | Item 5.02. Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers On… |
| 23.11.2020 | Item 5.02 — Abgang Schlüsselpersonen | – | HOCH | SEC | Item 5.02. Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers On… |
| 14.07.2020 | Item 5.02 — Abgang Schlüsselpersonen | – | HOCH | SEC | Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 13.03.2020 | Item 5.02 — Abgang Schlüsselpersonen | – | HOCH | SEC | Item 5.02. Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers On… |
8-K-Ereignisse (KI)
🔒 Die vollständige KI-Einordnung je 8-K ist Teil des Kunden-Abos — freischalten.
| Datum | Ereignis | Sentiment | Materialität | Zusammenfassung | Filing |
|---|---|---|---|---|---|
| 28.05.2026 | HV-Abstimmung | 0,00 | 35 | Corcept Therapeutics hielt am 21. Mai 2026 die jährliche Aktionärsversammlung ab. Die Aktionäre genehmigten die Wahl von acht Direktoren, di… 🔒 | SEC |
| 30.04.2026 | Quartalszahlen | 0,00 | 65 | Corcept Therapeutics gab am 30. April 2026 Finanzergebnisse für das erste Quartal 2026 und ein Unternehmens-Update bekannt. | SEC |
| 24.02.2026 | Quartalszahlen | 0,00 | 55 | Corcept Therapeutics veröffentlichte Geschäftsergebnisse für Q4 2025 sowie ein Unternehmens-Update. | SEC |
Fail-to-Deliver (6 Monate) ⓘ
| Datum | FTD-Menge | Kurs | Wert (USD) |
|---|---|---|---|
| 2026-06-30 | 170 | 87,89 | 14.941 |
| 2026-06-25 | 752 | 81,56 | 61.333 |
| 2026-06-23 | 318 | 79,71 | 25.348 |
| 2026-06-17 | 22.695 | 83,71 | 1.899.798 |
| 2026-06-16 | 24.342 | 83,12 | 2.023.307 |
| 2026-06-10 | 173 | 77,49 | 13.406 |
| 2026-06-01 | 28 | 69,49 | 1.946 |
| 2026-05-28 | 15.790 | 66,65 | 1.052.404 |
| 2026-05-18 | 1.066 | 56,37 | 60.090 |
| 2026-05-05 | 264 | 51,60 | 13.622 |
| 2026-05-01 | 99.904 | 46,52 | 4.647.534 |
| 2026-04-30 | 64 | 46,59 | 2.982 |
| 2026-04-23 | 93 | 46,57 | 4.331 |
| 2026-04-08 | 19 | 41,69 | 792 |
| 2026-04-06 | 53.237 | 42,49 | 2.262.040 |
| 2026-03-16 | 104 | 32,15 | 3.344 |
| 2026-03-13 | 102 | 32,39 | 3.304 |
| 2026-03-12 | 684 | 33,74 | 23.078 |
| 2026-03-10 | 697 | 33,99 | 23.691 |
| 2026-02-26 | 209 | 36,22 | 7.570 |
| 2026-02-11 | 1 | 40,97 | 41 |
| 2026-02-10 | 12 | 41,31 | 496 |
| 2026-02-02 | 2.124 | 39,87 | 84.684 |
Hinweis
Ersteller: Verantwortlich für Erstellung und Verbreitung ist der Betreiber dieser Website (siehe Impressum). Die Einstufung wird arbeitstäglich automatisiert neu berechnet — Stand: 28.07.2026.
Interessenkonflikte: Der Betreiber kann über verlinkte Anbieter (z. B. Broker) Affiliate-Vergütungen erhalten und ggf. eigene Positionen in besprochenen Werten halten. Methodik: Signal-Komponenten und Gewichte.